SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-077599
Filing Date
2023-07-03
Accepted
2023-07-03 16:06:03
Documents
12
Period of Report
2023-06-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320477d1_8k.htm   iXBRL 8-K 25797
  Complete submission text file 0001104659-23-077599.txt   199036

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20230627.xsd EX-101.SCH 2980
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20230627_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20230627_pre.xml EX-101.PRE 22373
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2320477d1_8k_htm.xml XML 3605
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 231065339
SIC: 2834 Pharmaceutical Preparations